GlobalData on MSN1d
GSK and University of Oxford partner for cancer vaccine research
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
pharmaphorum19h
OS data set up wider Jemperli use in endometrial cancer
GSK’s Jemperli has claimed an edge over its main rival in the endometrial cancer therapy market after showing improved overall survival in a broad patient population in the RUBY trial.
pharmaphorum1d
NICE backs frontline use of Jemperli in endometrial cancer
GSK’s PD-1 inhibitor Jemperli has been cleared for use by the NHS as a first-line treatment for a specific type of endometrial cancer, making it an option for around 580 women across England ...
Aifa, nuevos medicamentos reembolsados: aquí está la lista actualizada
L'Aifa, Agenzia Italiana del Farmaco, ha approvato 13 nuovi farmaci per il rimborso. Durante la prima riunione del 2025, il ...
GSK's depemokimab under review in China and Japan for asthma, CRSwNP
GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.31 billion and an impressive gross profit margin of 72.39%, has announced that its new drug applications ...
FiercePharma2d
Regulatory tracker: Merck's Welireg picks up FDA priority review in rare tumor bid
Also in Europe, officials have endorsed GSK's Jemperli to treat all adult patients with primary advanced or recurrent endometrial cancer, including those with mismatch repair proficient (MMRp ...
isanidad6d
Actualidad para la innovación farmacéutica
Redacción MSD presenta resultados positivos de un anticuerpo en investigación para virus respiratorio sincitial Merck Sharp & ...
Buy5d
Glaxosmithkline (GSK)
(Alliance News) - GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemotherapy, to include all adult patients with primary advanced or ...
Barclays Remains a Hold on GlaxoSmithKline (GSK)
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...
GSK, Oxford to establish GSK-Oxford Cancer Immuno-Prevention Programme
GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...
GSK says asthma and nasal polyps therapy under EU review
GSK (NYSE:GSK) announced Tuesday that the EU drug regulator has agreed to review depemokimab, an experimental monoclonal antibody targeting a class of cell signaling molecules called interleukin-5, ...
Yahoo Finance4d
GSK plc (GSK)
PLYMOUTH, Mass., January 13, 2025--GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based ...